Cite
HARVARD Citation
Smit, J. et al. (2022). Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Movement disorders. 37 (10), pp. 2045-2056. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Smit, J. et al. (2022). Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α‐Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Movement disorders. 37 (10), pp. 2045-2056. [Online].